The tale and trials of Efgartigimod: a newly FDA approved drug for the treatment of Myasthenia gravis
Not required
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Pakistan Medical Association
2022-10-01
|
Series: | Journal of the Pakistan Medical Association |
Online Access: | https://www.ojs.jpma.org.pk/index.php/public_html/article/view/6388 |